1. Home
  2. Labeler Index
  3. Accord Healthcare Inc.
  4. 16729-332
  5. Product Images: Oxaliplatin

Product Images Oxaliplatin

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 10 images provide visual information about the product associated with Oxaliplatin NDC 16729-332 by Accord Healthcare Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

oxaliplatin Injection, USP 100 mg/20 mL (5 mg/mL)-single-dose vial-Carton - oxaliplatin inj 100mg 20ml carton

oxaliplatin Injection, USP 100 mg/20 mL (5 mg/mL)-single-dose vial-Carton - oxaliplatin inj 100mg 20ml carton

This is a pharmaceutical product label for Oxaliplatin Injection USP used for intravenous use only. The product comes in a single-dose vial only, and sterile aqueous solution. The box contains a free disposable syringe for further required dispensation. The lot and expiry details are also given, along with the product's name. There is also a warning regarding overcoding and a blank area on the label.*

oxaliplatin Injection, USP 100 mg/20 mL (5 mg/mL)-single-dose vial-Label - oxaliplatin inj 100mg 20ml label

oxaliplatin Injection, USP 100 mg/20 mL (5 mg/mL)-single-dose vial-Label - oxaliplatin inj 100mg 20ml label

This is a cautionary label found on a medication vial. It warns that the medication contains a toxic agent and should only be used with a prescription. Users should discard any unused portion and refer to the packaging for proper storage instructions. The medication is intended for intravenous use only and must be diluted before use. It is stored in a temperature-controlled environment and must be protected from light. Further dosage and administration instructions are available in the package insert.*

oxaliplatin Injection, USP 200 mg/40 mL (5 mg/mL)-single-dose vial-Carton - oxaliplatin inj 200mg 40ml carton

oxaliplatin Injection, USP 200 mg/40 mL (5 mg/mL)-single-dose vial-Carton - oxaliplatin inj 200mg 40ml carton

This appears to be a mixture of different types of information, including what seems to be a label for a medication containing "Oxaliplatin" used for intravenous injections, dosing information (200mg/40mL), storage instructions, and warnings. There are also some references to other products or items, such as "bark & varichifee" and a "Lotand BP 2107". The rest of the text is difficult to read or seems to be a mix of words and characters that do not form coherent sentences or phrases.*

oxaliplatin Injection, USP 200 mg/40 mL (5 mg/mL)-single-dose vial-Label - oxaliplatin inj 200mg 40ml label

oxaliplatin Injection, USP 200 mg/40 mL (5 mg/mL)-single-dose vial-Label - oxaliplatin inj 200mg 40ml label

This is a cautionary label of a medication containing Oxaliplatin, a cytotoxic agent. The medication comes in a vial of 200mg and should be discarded if unused. The dosage and administration should be done by a healthcare professional via intravenous use only. It should be stored at room temperature, between 20° to 25°C (68° to 77°F), protecting it from light and should not be frozen. Further instructions can be found in the package insert.*

oxaliplatin Injection, USP 50 mg/10 mL (5 mg/mL)-single-dose-Carton - oxaliplatin inj 50mg 10ml carton

oxaliplatin Injection, USP 50 mg/10 mL (5 mg/mL)-single-dose-Carton - oxaliplatin inj 50mg 10ml carton

Not available. The text seems to be a mix of medical and technical information, including drug names, product packaging, and usage instructions. However, it contains many errors and incomplete sentences that make it difficult to understand.*

oxaliplatin Injection, USP 50 mg/10 mL (5 mg/mL)-single-dose vial-Label - oxaliplatin inj 50mg 10ml label

oxaliplatin Injection, USP 50 mg/10 mL (5 mg/mL)-single-dose vial-Label - oxaliplatin inj 50mg 10ml label

This is a medication that comes in a kit for intravenous use only. It contains oxaliplatin USP, 50mg and is a preservative-free aqueous solution with a concentration of 5mg/mL. The medication should not be added to sodium chloride and should only be used with chloride-containing solutions. The packaging has a varnish-free area of 23x18mm. No further information is available.*

Figure 1 - oxaliplatin inj figure 1

Figure 1 - oxaliplatin inj figure 1

This is a chart displaying DFS Probability values for two treatments (FOLFOX4 and LVBEUZ) with corresponding hazard ratio and stratified logrank test result. The chart also shows the number of events and number of patients at risk for each treatment at different months.*

Figure 2 - oxaliplatin inj figure 2

Figure 2 - oxaliplatin inj figure 2

Figure 3 - oxaliplatin inj figure 3

Figure 3 - oxaliplatin inj figure 3

This is a survival analysis chart for different chemotherapy treatments. It shows the percentage of patients surviving over the course of months for each treatment option. The chart also displays the median survival rate in months for each treatment. The log rank test was used to compare the effectiveness of Eloxatin plus 5-FU/LV and irinotecan plus 5-FU/LV.*

chemical structure - oxaliplatin inj structure

chemical structure - oxaliplatin inj structure

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.